VA Psilocybin Trial Will Enroll 240 Veterans
The VA psilocybin trial, called PIVOT, is a Phase 3 study in veterans with treatment-resistant depression. Nobody has been dosed yet.
35 Attorneys General Fought the Hemp Ban Delay
A bipartisan attorneys general hemp ban letter urged Congress to reject any delay of the November 12 recriminalization date. Four days later, they lost.
Dr. Oz Hemp Letter Urged Senate to Delay Ban
The Dr. Oz hemp letter asked senators to reject the Budd amendment so Medicare beneficiaries could keep getting hemp-derived CBD coverage.
Senate Hemp Ban Delay Passes on 61-32 Vote
The Senate hemp ban delay advanced 61-32 at 2:36 a.m. on August 8, pushing federal hemp recriminalization from November 12 to December 11.
The IRS Wants Its 280E Refunds Back — TerrAscend Sued for $8.3 Million
The 280E refund gold rush just met the collections department. The Department of Justice is suing multistate operator TerrAscend for $8.3 million plus interest, arguing the refund it collected on amended returns was “erroneous” because the deductions were barred by Section 280E (the docket is here; MJBiz coverage here). TerrAscend received the money in June […]
Pentagon: Rescheduling Doesn’t Change the Military Marijuana Ban
If you serve, you still can’t smoke. That is the entire message of a one-page Department of War memo, dated July 9 and obtained by Marijuana Moment, reminding senior Pentagon leadership that the military marijuana prohibition survives federal rescheduling completely intact. The department “maintains a drug-free workplace to protect national security, public safety, and operational […]
Schumer’s Cannabis Administration and Opportunity Act Is Back — With Union Muscle
One day after the DEA closed the record on rescheduling, Congress raised the bid. On July 16, Senate Minority Leader Chuck Schumer and Senators Cory Booker and Ron Wyden reintroduced the Cannabis Administration and Opportunity Act — the comprehensive bill that would remove marijuana from the Controlled Substances Act entirely. Not Schedule III. Not a […]
The Marijuana Rescheduling Hearing Is Over — Now One Judge Decides
The marijuana rescheduling hearing is over. After two weeks of testimony at DEA headquarters in Arlington, the evidentiary hearing on moving marijuana to Schedule III wrapped up on July 15 — and here is what a searcher actually wants to know: Chief Administrative Law Judge Derek Julius gave participants until August 17 to file post-hearing […]
The KIDS Act Passed the House — and It Quietly Hits Cannabis Ads
KIDS Act: A Hidden Cannabis Advertising Ban If you run cannabis advertising anywhere online, a “kids’ safety” bill you probably didn’t read just became your problem. On June 29 the U.S. House voted 267–117 to pass the Kids Internet and Digital Safety (KIDS) Act, and buried in the text is a provision that could seriously […]
DEA Rescheduling Hearing, Week Two: A Pain Doctor Takes the Stand
DEA Rescheduling Hearing: Week Two Testimony The DEA rescheduling hearing came back from its Fourth-of-July recess and kept doing the thing that still surprises people: the government is building the record for moving marijuana to Schedule III. The two-week administrative proceeding recessed July 3, reconvened July 6, and runs no later than July 15. Week […]